{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:51:00Z","timestamp":1791921060048,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Leiden University Medical Center (LUMC)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00125-017-4322-3","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T14:20:08Z","timestamp":1497536408000},"page":"1813-1821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes"],"prefix":"10.1007","volume":"60","author":[{"given":"Pascal","family":"Bus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Scharpfenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Van Der Wilk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Wolterbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Baelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"4322_CR1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0703393","volume":"130","author":"AS Vriese De","year":"2000","unstructured":"De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130:963\u2013974","journal-title":"Br J Pharmacol"},{"key":"4322_CR2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev-physiol-021115-105412","volume":"78","author":"CS Bartlett","year":"2016","unstructured":"Bartlett CS, Jeansson M, Quaggin SE (2016) Vascular growth factors and glomerular disease. Annu Rev Physiol 78:437\u2013461","journal-title":"Annu Rev Physiol"},{"key":"4322_CR3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J et al (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129\u20131136","journal-title":"N Engl J Med"},{"key":"4322_CR4","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2337\/diabetes.48.11.2229","volume":"48","author":"ME Cooper","year":"1999","unstructured":"Cooper ME, Vranes D, Youssef S et al (1999) Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48:2229\u20132239","journal-title":"Diabetes"},{"key":"4322_CR5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s001250051198","volume":"42","author":"K Tsuchida","year":"1999","unstructured":"Tsuchida K, Makita Z, Yamagishi S et al (1999) Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 42:579\u2013588","journal-title":"Diabetologia"},{"key":"4322_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/bbrc.2001.6138","volume":"290","author":"S Hoshi","year":"2002","unstructured":"Hoshi S, Nomoto K, Kuromitsu J, Tomari S, Nagata M (2002) High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun 290:177\u2013184","journal-title":"Biochem Biophys Res Commun"},{"key":"4322_CR7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1681\/ASN.V125993","volume":"12","author":"AS Vriese De","year":"2001","unstructured":"De Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH (2001) Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12:993\u20131000","journal-title":"J Am Soc Nephrol"},{"key":"4322_CR8","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/diabetes.51.10.3090","volume":"51","author":"A Flyvbjerg","year":"2002","unstructured":"Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R (2002) Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51:3090\u20133094","journal-title":"Diabetes"},{"key":"4322_CR9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ndt\/gfi217","volume":"21","author":"BF Schrijvers","year":"2006","unstructured":"Schrijvers BF, Flyvbjerg A, Tilton RG, Lameire NH, De Vriese AS (2006) A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Nephrol Dial Transplant 21:324\u2013329","journal-title":"Nephrol Dial Transplant"},{"key":"4322_CR10","first-page":"377","volume":"61","author":"GR Gallo","year":"1970","unstructured":"Gallo GR (1970) Elution studies in kidneys with linear deposition of immunoglobulin in glomeruli. Am J Pathol 61:377\u2013394","journal-title":"Am J Pathol"},{"key":"4322_CR11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1523-1755.2004.00367.x","volume":"65","author":"F Chow","year":"2004","unstructured":"Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH (2004) Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 65:116\u2013128","journal-title":"Kidney Int"},{"key":"4322_CR12","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/ndt\/gfh441","volume":"19","author":"FY Chow","year":"2004","unstructured":"Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH (2004) Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant 19:2987\u20132996","journal-title":"Nephrol Dial Transplant"},{"key":"4322_CR13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.172.6.1535","volume":"172","author":"M Clauss","year":"1990","unstructured":"Clauss M, Gerlach M, Gerlach H et al (1990) Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535\u20131545","journal-title":"J Exp Med"},{"key":"4322_CR14","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336","volume":"87","author":"B Barleon","year":"1996","unstructured":"Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336\u20133343","journal-title":"Blood"},{"key":"4322_CR15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/labinvest.2008.60","volume":"88","author":"W Sato","year":"2008","unstructured":"Sato W, Kosugi T, Zhang L et al (2008) The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy. Lab Investig 88:949\u2013961","journal-title":"Lab Investig"},{"key":"4322_CR16","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M009705200","volume":"276","author":"I Kim","year":"2001","unstructured":"Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-\u03baB activation in endothelial cells. J Biol Chem 276:7614\u20137620","journal-title":"J Biol Chem"},{"key":"4322_CR17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.33549\/physiolres.930343","volume":"53","author":"TS Altannavch","year":"2004","unstructured":"Altannavch TS, Roubalova K, Kucera P, Andel M (2004) Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol Res 53:77\u201382","journal-title":"Physiol Res"},{"key":"4322_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jcp.2005.035592","volume":"60","author":"KO Alsaad","year":"2007","unstructured":"Alsaad KO, Herzenberg AM (2007) Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol 60:18\u201326","journal-title":"J Clin Pathol"},{"key":"4322_CR19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1089\/hum.2006.176","volume":"18","author":"D Eefting","year":"2007","unstructured":"Eefting D, Grimbergen JM, de Vries MR et al (2007) Prolonged in vivo gene silencing by electroporation-mediated plasmid delivery of small interfering RNA. Hum Gene Ther 18:861\u2013869","journal-title":"Hum Gene Ther"},{"key":"4322_CR20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nprot.2010.6","volume":"5","author":"I Arnaoutova","year":"2010","unstructured":"Arnaoutova I, Kleinman HK (2010) In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 5:628\u2013635","journal-title":"Nat Protoc"},{"key":"4322_CR21","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.2337\/DB11-1655","volume":"61","author":"GA Sivaskandarajah","year":"2012","unstructured":"Sivaskandarajah GA, Jeansson M, Maezawa Y, Eremina V, Baelde HJ, Quaggin SE (2012) Vegfa protects the glomerular microvasculature in diabetes. Diabetes 61:2958\u20132966","journal-title":"Diabetes"},{"key":"4322_CR22","doi-asserted-by":"crossref","first-page":"F214","DOI":"10.1152\/ajprenal.00204.2005","volume":"290","author":"SB Gurley","year":"2006","unstructured":"Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM (2006) Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290:F214\u2013F222","journal-title":"Am J Physiol Renal Physiol"},{"key":"4322_CR23","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1681\/ASN.2006010064","volume":"17","author":"SH Sung","year":"2006","unstructured":"Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S (2006) Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 17:3093\u20133104","journal-title":"J Am Soc Nephrol"},{"key":"4322_CR24","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.2337\/db08-0647","volume":"57","author":"CH Ku","year":"2008","unstructured":"Ku CH, White KE, Dei Cas A et al (2008) Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Diabetes 57:2824\u20132833","journal-title":"Diabetes"},{"key":"4322_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2005-861027","volume":"37","author":"BF Schrijvers","year":"2005","unstructured":"Schrijvers BF, De Vriese AS, Tilton RG et al (2005) Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes. Horm Metab Res 37:21\u201325","journal-title":"Horm Metab Res"},{"key":"4322_CR26","doi-asserted-by":"crossref","first-page":"F609","DOI":"10.1152\/ajprenal.00377.2009","volume":"298","author":"T Kosugi","year":"2010","unstructured":"Kosugi T, Nakayama T, Li Q et al (2010) Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice. Am J Physiol Ren Physiol 298:F609\u2013F616","journal-title":"Am J Physiol Ren Physiol"},{"key":"4322_CR27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nri3582","volume":"14","author":"M Guilliams","year":"2014","unstructured":"Guilliams M, Bruhns P, Saeys Y, Hammad H, Lambrecht BN (2014) The function of Fc\u03b3 receptors in dendritic cells and macrophages. Nat Rev Immunol 14:94\u2013108","journal-title":"Nat Rev Immunol"},{"key":"4322_CR28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2012.08.037","volume":"151","author":"J Jin","year":"2012","unstructured":"Jin J, Sison K, Li C et al (2012) Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell 151:384\u2013399","journal-title":"Cell"},{"key":"4322_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199807093390202","volume":"339","author":"P Fioretto","year":"1998","unstructured":"Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69\u201375","journal-title":"N Engl J Med"},{"key":"4322_CR30","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V97.3.785","volume":"97","author":"A Sawano","year":"2001","unstructured":"Sawano A, Iwai S, Sakurai Y et al (2001) Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97:785\u2013791","journal-title":"Blood"},{"key":"4322_CR31","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diabetes.54.9.2628","volume":"54","author":"Z Qi","year":"2005","unstructured":"Qi Z, Fujita H, Jin J et al (2005) Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 54:2628\u20132637","journal-title":"Diabetes"},{"key":"4322_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s001250050888","volume":"41","author":"K Hirata","year":"1998","unstructured":"Hirata K, Shikata K, Matsuda M et al (1998) Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia 41:185\u2013192","journal-title":"Diabetologia"},{"key":"4322_CR33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2796.2004.01350.x","volume":"256","author":"ES Leinonen","year":"2004","unstructured":"Leinonen ES, Hiukka A, Hurt-Camejo E et al (2004) Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes. J Intern Med 256:119\u2013127","journal-title":"J Intern Med"},{"key":"4322_CR34","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1159\/000438571","volume":"37","author":"Z Yu","year":"2015","unstructured":"Yu Z, Zhang Y, Gao N, Yong K (2015) Suppression of development of ankylosing spondylitis through soluble Flt-1. Cell Physiol Biochem 37:2135\u20132142","journal-title":"Cell Physiol Biochem"},{"key":"4322_CR35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/cei.12758","volume":"184","author":"F Biscetti","year":"2016","unstructured":"Biscetti F, Flex A, Pecorini G et al (2016) The role of high-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on vascular endothelial growth factor. Clin Exp Immunol 184:62\u201372","journal-title":"Clin Exp Immunol"},{"key":"4322_CR36","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/hc0902.104718","volume":"105","author":"Q Zhao","year":"2002","unstructured":"Zhao Q, Egashira K, Inoue S et al (2002) Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting\/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 105:1110\u20131115","journal-title":"Circulation"},{"key":"4322_CR37","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1161\/01.CIR.0000145123.85083.66","volume":"110","author":"K Ohtani","year":"2004","unstructured":"Ohtani K, Egashira K, Hiasa K et al (2004) Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation 110:2444\u20132452","journal-title":"Circulation"},{"key":"4322_CR38","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1097\/01.CCM.0000275273.56547.B8","volume":"35","author":"PN Tsao","year":"2007","unstructured":"Tsao PN, Chan FT, Wei SC et al (2007) Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis. Crit Care Med 35:1955\u20131960","journal-title":"Crit Care Med"},{"key":"4322_CR39","doi-asserted-by":"crossref","first-page":"21264","DOI":"10.1073\/pnas.0907550106","volume":"106","author":"HB Schonthaler","year":"2009","unstructured":"Schonthaler HB, Huggenberger R, Wculek SK, Detmar M, Wagner EF (2009) Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci U S A 106:21264\u201321269","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4322_CR40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.2015.162","volume":"4","author":"AS Awad","year":"2015","unstructured":"Awad AS, You H, Gao T et al (2015) Macrophage-derived tumor necrosis factor-alpha mediates diabetic renal injury. Kidney Int 4:722\u2013733","journal-title":"Kidney Int"},{"key":"4322_CR41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1258\/la.2010.010090","volume":"45","author":"MC Deeds","year":"2011","unstructured":"Deeds MC, Anderson JM, Armstrong AS et al (2011) Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab Anim 45:131\u2013140","journal-title":"Lab Anim"},{"key":"4322_CR42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/taap.1995.1234","volume":"135","author":"AR Kraynak","year":"1995","unstructured":"Kraynak AR, Storer RD, Jensen RD et al (1995) Extent and persistence of streptozotocin-induced DNA damage and cell proliferation in rat kidney as determined by in vivo alkaline elution and BrdUrd labeling assays. Toxicol Appl Pharmacol 135:279\u2013286","journal-title":"Toxicol Appl Pharmacol"},{"key":"4322_CR43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ki.2009.208","volume":"76","author":"S Bodin","year":"2009","unstructured":"Bodin S, Chollet C, Goncalves-Mendes N et al (2009) Kallikrein protects against microalbuminuria in experimental type I diabetes. Kidney Int 76:395\u2013403","journal-title":"Kidney Int"},{"key":"4322_CR44","doi-asserted-by":"crossref","first-page":"F487","DOI":"10.1152\/ajprenal.00018.2010","volume":"299","author":"J Xu","year":"2010","unstructured":"Xu J, Huang Y, Li F, Zheng S, Epstein PN (2010) FVB mouse genotype confers susceptibility to OVE26 diabetic albuminuria. Am J Physiol Ren Physiol 299:F487\u2013F494","journal-title":"Am J Physiol Ren Physiol"},{"key":"4322_CR45","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.mvr.2009.01.002","volume":"77","author":"T Hara","year":"2009","unstructured":"Hara T, Ishida T, Cangara HM, Hirata K (2009) Endothelial cell-selective adhesion molecule regulates albuminuria in diabetic nephropathy. Microvasc Res 77:348\u2013355","journal-title":"Microvasc Res"},{"key":"4322_CR46","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2007.060481","volume":"170","author":"Y Kanetsuna","year":"2007","unstructured":"Kanetsuna Y, Takahashi K, Nagata M et al (2007) Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol 170:1473\u20131484","journal-title":"Am J Pathol"},{"key":"4322_CR47","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/HYPERTENSIONAHA.113.01115","volume":"61","author":"IM Craici","year":"2013","unstructured":"Craici IM, Wagner SJ, Bailey KR et al (2013) Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 61:1289\u20131296","journal-title":"Hypertension"},{"key":"4322_CR48","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/ndt\/gfh129","volume":"19","author":"KE White","year":"2004","unstructured":"White KE, Bilous RW, Diabiopsies Study Group (2004) Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 19:1437\u20131440","journal-title":"Nephrol Dial Transplant"},{"key":"4322_CR49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2353\/ajpath.2006.050398","volume":"168","author":"D Macconi","year":"2006","unstructured":"Macconi D, Bonomelli M, Benigni A et al (2006) Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 168:42\u201354","journal-title":"Am J Pathol"},{"key":"4322_CR50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","volume":"111","author":"V Eremina","year":"2003","unstructured":"Eremina V, Sood M, Haigh J et al (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Investig 111:707\u2013716","journal-title":"J Clin Investig"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4322-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4322-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4322-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:36:15Z","timestamp":1692840975000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4322-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["4322"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4322-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]}}}